Description
Inclusion body myositis (IBM) represents an uncommon, persistent, and progressive muscle disease that mainly affects elderly persons. IBM belongs to a class of diseases known as inflammatory myopathies, which are typified by muscular atrophy, weakness, and inflammation. The disease mostly affects skeletal muscles, primarily those in the throat, arms, and legs. Its unique characteristic is the aberrant protein deposits seen inside the muscle cells, which cause the muscles to gradually weaken and degenerate.
The gradual development of IBM is characterized by quadriceps muscle weakness, which makes it difficult to get out of a chair or climb stairs. It affects daily actions including walking, lifting things, and swallowing as it spreads to additional muscle groups over time. The muscles that regulate bladder or bowel activities and eye movements are typically spared by IBM.
You May Also Like:
Bullous pemphigoid: Description, Causes, and Treatment Protocol
CREST syndrome | Limited cutaneous systemic sclerosis: Description, Causes, and Treatment Protocol
Inclusion body myositis: Description, Causes, and Treatment Protocol is an original (MedNewsPedia) article.
Possible Causes
It is thought that IBM is a complex syndrome driven by an interaction of immune-mediated, genetic, and environmental variables, with the exact etiology of the disorder still unknown. The following are some possible causes that the researchers think might be connected to IBM:
Immune System Dysregulation: IBM is classified as an autoimmune disease, i.e., the immune system of the body destroys its tissues by mistake. Muscle fiber injury, inflammation, and the creation of aberrant protein aggregates are all results of an aberrant immunological response within muscle cells. The emergence and spread of IBM may be attributed to immune system instability, particularly an imbalance in immunological reactions.
Genetic Aspects: While genetic mutations or changes may not be a strict hereditary condition, they may predispose an individual to the development of IBM. IBM risk may be elevated in the event of a family record of inflammatory myopathies.
Environmental Aspects: Exposures or environmental factors may contribute to the development or worsening of IBM. Nevertheless, the precise identification of particular environmental elements or triggers remains obscure.
Muscle Weakening and Protein Aggregates: Beta-amyloid and tau are examples of aberrant protein clumps that build up inside muscle cells affected by IBM. These protein buildups may interfere with regular biological functions and cause inflammation and deterioration in the muscles.
Oxidative Damage and Mitochondrial Dysfunction: According to certain research, the underlying cause of IBM may include mitochondrial malfunction and oxidative stress in muscle cells. Muscle deterioration and weakness may be caused by mitochondrial defects and reduced energy synthesis in muscle cells.
Age-Related Changes: Older individuals are the primary target population for IBM, and the condition may arise as a result of aging-related changes. The initial stage or progression of IBM may be influenced by age-related changes in immune system function or cellular processes.
Exacerbating and Mitigating Factors
Multiple factors might either aggravate or alleviate the symptoms of IBM. It is significant to comprehend these exacerbated and mitigated aspects to control the disease’s course and enhance the lives of those who are impacted by IBM. Some of these factors are as follows:
The exacerbating factors include:
Age: The majority of individuals affected by IBM are aged 50 years or older. This condition is more common as people start aging. Getting older is thought to increase the chance of acquiring the disease.
Gender: Although both genders are susceptible to IBM, certain research indicates a marginally greater incidence in men.
Genetic Predisposition: While the precise genetic pathways of IBM are not entirely understood, there may be a hereditary propensity or familial tendency for the disorder.
Immune Dysfunction: An abnormal immunological reaction that causes the immune system to target healthy muscle tissue is what defines IBM. Muscle degeneration and inflammation are made worse by this immunological malfunction.
Environmental Triggers: The onset or worsening of IBM may be attributed to specific environmental conditions or triggers, though these have not been well-identified.
Overuse or Damage to Muscles: When someone has IBM, their muscular weakness and inflammation may worsen with intense physical exercise or repetitive muscle activation.
Medication Interactions: IBM or its drugs may interact negatively with some therapies or pharmaceuticals used for managing other disorders, which could make symptoms more acute.
The mitigating factors include:
Exercise and Physical Therapy: Personalized exercise regimens created by physical therapy professionals may reduce muscular weakness and stop atrophy by preserving muscle power, flexibility, and mobility.
Occupational Therapy: To help individuals become more independent and functional, occupational therapists provide strategies for modifying everyday tasks to account for muscle weakness.
Medication Management: Even though there fails to be an approved remedy, some people may find that taking IL-6 inhibitors or immunosuppressants helps control symptoms and slow down the progression of their disorder.
Lifestyle Changes: Maintaining a proper weight, quitting smoking, and eating a well-balanced, nutrient-rich diet can all improve general health and possibly even assist in minimizing IBM symptoms.
Assistive Devices: People with muscle weakness can increase their independence, reduce their risk of falling, and increase their mobility by using walkers, canes, or other assistive technology.
Stress Management: Since stress can sometimes make symptoms worse, reducing stress through meditation, relaxation techniques, or therapy may help enhance general well-being.
Regular Monitoring: IBM can be managed and early intervention is aided by attentive observation of symptoms and routine check-ups with medical professionals.
Standard Treatment Protocol
Since there is no confirmed treatment for IBM, the usual course of treatment focuses on symptom management, delaying the disease’s development, and enhancing quality of life. An overview of the customary methods of care for IBM is provided below:
Medications: These incorporate:
Corticosteroids
Traditionally, corticosteroids were employed to treat IBM for reducing inflammation caused by the immune system. However, their effectiveness is still limited, and in the long run, the negative effects can exceed the positive ones.
Immunosuppressants
To control the immunological response, doctors may administer medications such as intravenous immunoglobulin (IVIG) or methotrexate.
Investigational Drugs: These involve:
Rapamycin (Sirolimus)
This immunosuppressant can slow down the deterioration of muscles, but more research is required to prove its effectiveness in IBM.
Tocilizumab
According to certain research, this interleukin-6 receptor inhibitor may be able to decrease muscle weakness and inflammation.
Mobility Aids: For individuals who are experiencing muscle weakness, using walkers, braces, canes, or other assistance equipment may be necessary to improve movement and prevent tripping and falling.
Observation and Assistance: To properly manage symptoms and assess the evolution of the disease, healthcare practitioners must check patients regularly. Counseling and psychological support could be helpful for people with the emotional difficulties of having a chronic illness like IBM.
Treatment Options
People suffering from IBM may consider other forms of adjunct therapy and treatment choices alongside the regular medical protocols. The supplementary treatment alternatives for IBM are outlined below:
Over-the-Counter Formulations: This includes nonsteroidal anti-inflammatory medications (NSAIDs) that may decrease inflammation and reduce pain.
Nutritional Supplements: These include:
Creatine Monohydrate
In some persons, it can increase muscle function and strength. To give muscles energy during high-intensity activity, creatine monohydrate aids in the synthesis of ATP.
Vitamin D
It may have immunomodulatory effects and promote bone health. Exposure to sunshine and the intake of specific foods, like egg yolks, fatty fish, and dairy products with added fortification, are the most common means to acquire vitamin D.
Vitamin B12
It may help to relieve fatigue and is required for nerve function. Vitamin B12 can be obtained from supplements and food sources like dairy, meat, fish, and fortified cereals.
Coenzyme Q10 (CoQ10)
It promotes mitochondrial activity and has antioxidant properties. CoQ10 might aid in decreasing oxidative stress, which may be a factor in muscle deterioration.
Omega-3 Fatty Acids
Owing to their well-known anti-inflammatory qualities, omega-3 fatty acids may help reduce muscular inflammation linked to IBM.
Herbal and Natural Remedies: These involve:
Ginger
It has anti-inflammatory and maybe analgesic effects. These properties of ginger may help reduce muscle soreness and inflammation.
Turmeric/Curcumin
Curcumin, which is present in turmeric and is well known for having anti-inflammatory properties, might be able to reduce inflammation linked to IBM.
Green Tea
Antioxidants and substances with potential anti-inflammatory properties have been identified in green tea. As a result, it might help lower oxidative stress.
Arnica
As per some individuals, arnica relieves pain. It is usually applied topically as a gel or cream.
Bromelain
Pineapples contain an enzyme named bromelain, which may have anti-inflammatory qualities. Often, bromelain is utilized to support muscle functioning.
Alternative Therapies: These incorporate:
Acupuncture
Certain individuals find this technique beneficial in alleviating pain and enhancing muscular function.
Yoga
It may be possible to retain mobility, reduce stress, and increase flexibility using gentle yoga positions and breathing techniques.
Massage Therapy
While its long-term advantages for treating IBM are not firmly established massage therapy might provide momentary alleviation from muscle stiffness.
However, for the management of IBM symptoms, people should adopt a customized, integrative strategy that combines standard medical care with complementary therapies. Such personalized treatment regimens ought to be developed after considering each patient’s needs, preferences, and advice from medical specialists.
Conclusion
Inclusion body myositis (IBM) remains a challenging, progressive muscle disorder with no definitive cure. Its complex nature, involving immune dysregulation, protein aggregation, and age-related changes, underscores the need for a comprehensive and individualized approach to management. While conventional treatments focus on symptom relief, delaying disease progression, and enhancing quality of life, adjunct therapies such as exercise, nutritional supplementation, and alternative remedies offer additional support. A multidisciplinary strategy, including medical care, physical therapy, and lifestyle modifications, can empower patients to manage symptoms and maintain independence. Ongoing research into emerging treatments and novel interventions brings hope for improved outcomes and greater understanding of IBM, highlighting the importance of continued collaboration between patients, healthcare providers, and researchers.
Additional resources for further reference
https://www.frontiersin.org/articles/10.3389/fneur.2022.1020113/full
https://link.springer.com/article/10.1007/s13311-018-0658-8
https://actaneurocomms.biomedcentral.com/articles/10.1186/s40478-022-01389-6
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00327-7/fulltext
Important Note: The information contained in this article is for general informational purposes only, and should not be construed as health or medical advice, nor is it intended to diagnose, prevent, treat, or cure any disease or health condition. Before embarking on any diet, fitness regimen, or program of nutritional supplementation, it is advisable to consult your healthcare professional in order to determine its safety and probable efficacy in terms of your individual state of health.
Regarding Nutritional Supplements Or Other Non-Prescription Health Products: If any nutritional supplements or other non-prescription health products are mentioned in the foregoing article, any claims or statements made about them have not been evaluated by the U.S. Food and Drug Administration, and such nutritional supplements or other health products are not intended to diagnose, treat, cure, or prevent any disease.
